ArticleCancers2021
hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA.
Karen Aughton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ArticleCancers2021
Karen Aughton et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.